Form 144 Kanzhun Ltd Filed by: Chen Xu
- S&P 500 wobbles to lower close on mixed Fed messages, strong GDP data
- Economic outlook deteriorates as growth, inflation slows: Fed's Beige Book
- Cigna, Humana explore healthcare megamerger - WSJ
- Stocks will be hostage to earnings delivery in 2024 rather than yields - JPMorgan
- General Motors (GM) surges on $10 billion buyback plan, increased dividend
|Form 144 Filer Information||
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
144: Filer Information
|Is this a LIVE or TEST Filing?||LIVE TEST|
Submission Contact Information
144: Issuer Information
|Name of Issuer|
|SEC File Number|
|Address of Issuer|
PO Box 309, Ugland House
|Name of Person for Whose Account the Securities are To Be Sold|
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
|Relationship to Issuer|
144: Securities Information
|Title of the Class of Securities To Be Sold||Name and Address of the Broker||Number of Shares or Other Units To Be Sold||Aggregate Market Value||Number of Shares or Other Units Outstanding||Approximate Date of Sale||Name the Securities Exchange|
|American Depositary Shares, each representing two Class A Ordinary Shares|
Futu Securities International (Hong Kong) Limited
11/F, Bangkok Bank Building
18 Bonham Strand West
Sheung Wan K3 00000
Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:
144: Securities To Be Sold
|Title of the Class||Date you Acquired||Nature of Acquisition Transaction||Name of Person from Whom Acquired||Is this a Gift?||Date Donor Acquired||Amount of Securities Acquired||Date of Payment||Nature of Payment *|
|Ordinary Shares||02/18/2021||Employee equity incentive award||Issuer||400000||09/22/2023||Services rendered|
* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
144: Securities Sold During The Past 3 Months
|Nothing to Report|
144: Remarks and Signature
 As of 8/31/2023, Issuer has 869,812,906 ordinary shares outstanding on an as-converted basis, including 730,182,505 Class A Ordinary Shares, and 139,630,401 Class B Ordinary Shares (excluding the 20,340,598 Class A Ordinary Shares issued to the depositary for bulk-issuance of ADSs reserved for future issuances upon the exercise or vesting of awards granted under the Issuer's Share Incentive Plans), as reported in the Form 6-K filed by Issuer on 9/7/2023. Each ADS represents 2 Class A Ordinary Shares of the Issuer.  Seller is scheduled to exercise previously granted employee stock options. Upon exercising the options and paying the applicable exercise price, Seller is to be issued Class A Ordinary Shares of the Issuer that have been previously registered on the Issuer's Form S-8.  Aggregate Market Value is as of 9/18/2023.
|Date of Notice|
|The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.|
/s/ CHEN Xu
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement
- Phunware Appoints Jeremy Kidd as Senior Vice President of Sales and Marketing
- LifeVantage® Study Reveals Synergistic Effects of Protandim® Nrf2 Synergizer® and TrueScience® Liquid Collagen
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!